Cumate-inducible models of MYC-driven neuroblastoma identify mitoribosomal synthetic lethality as a precision oncology vulnerability in MYC(N)-amplified tumors
Adela Kubistova, I. R. Horak, Tomáš Bárta, Marie Šulová, Martin Marek, Jaroslav Štěrba, Karolina Borankova, Jan Skoda
This paper develops a cumate-inducible model to study MYC-driven neuroblastoma and identifies mitoribosomal synthetic lethality as a therapeutic target in MYC(N)-amplified tumors.
bioRxiv · Oct 1, 2026 · PreprintCancer Biology